These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Diagnosis and nonsurgical treatment of hepatocellular carcinoma. Okuda K Hepatogastroenterology; 1990 Apr; 37(2):159-64. PubMed ID: 2160418 [No Abstract] [Full Text] [Related]
7. A case of hepatocellular adenomatosis with a follow-up of 11 years. Propst A; Propst T; Waldenberger P; Vogel W; Judmaier G Am J Gastroenterol; 1995 Aug; 90(8):1345-6. PubMed ID: 7639246 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis of hepatocellular carcinoma (HCC) in a high-risk patient by using transgastric EUS-guided fine-needle biopsy (EUS-FNA). Hollerbach S; Reiser M; Topalidis T; König M; Schmiegel W Z Gastroenterol; 2003 Oct; 41(10):995-8. PubMed ID: 14562197 [TBL] [Abstract][Full Text] [Related]
9. Combined hepatocellular and cholangiocellular carcinoma. Murakami T; Kim T; Tomoda K; Narumi Y; Sakon M; Wakasa K; Nakamura H Radiat Med; 1997; 15(4):243-6. PubMed ID: 9311042 [TBL] [Abstract][Full Text] [Related]
10. Hepatic ultrasonography in type I glycogen storage disease (von Gierke disease). Detection of hepatic adenoma and carcinoma. Grossman H; Ram PC; Coleman RA; Gates G; Rosenberg ER; Bowie JD; Wilkinson RH Radiology; 1981 Dec; 141(3):753-6. PubMed ID: 6272355 [No Abstract] [Full Text] [Related]
11. Percutaneous ethanol injection therapy for hepatocellular carcinoma: validity of MR imaging in the evaluation of treatment effect. Usui H; Itai Y Radiat Med; 1995; 13(3):103-8. PubMed ID: 7569000 [TBL] [Abstract][Full Text] [Related]
12. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)]. De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241 [TBL] [Abstract][Full Text] [Related]
13. Independent occurrence of hepatocellular and cholangiocellular cancer nodules in the liver. Furuta T; Kanematsu T; Sonoda T; Sugimachi K Eur J Surg Oncol; 1987 Feb; 13(1):69-73. PubMed ID: 3028868 [TBL] [Abstract][Full Text] [Related]
14. Imaging diagnosis of hepatocellular carcinoma with differentiation from other pathology. Kim TK; Jang HJ; Wilson SR Clin Liver Dis; 2005 May; 9(2):253-79. PubMed ID: 15831272 [TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and follow-up of tumors and metastases of the liver using imaging techniques]. Schwickert H; Thelen M Aktuelle Radiol; 1993 May; 3(3):144-51. PubMed ID: 8390861 [TBL] [Abstract][Full Text] [Related]
16. Primary hepatocellular lesions: imaging findings on state-of-the-art magnetic resonance imaging, with pathologic correlation. van den Bos IC; Hussain SM; de Man RA; Zondervan PE; Ijzermans JN; Krestin GP Curr Probl Diagn Radiol; 2008; 37(3):104-14. PubMed ID: 18436110 [TBL] [Abstract][Full Text] [Related]
17. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Torzilli G; Minagawa M; Takayama T; Inoue K; Hui AM; Kubota K; Ohtomo K; Makuuchi M Hepatology; 1999 Oct; 30(4):889-93. PubMed ID: 10498639 [TBL] [Abstract][Full Text] [Related]
18. A case of type Ia glycogen storage disease complicated by hepatic adenoma. Fujiyama S; Sato K; Sakai M; Sato T; Tashiro S; Arakawa M Hepatogastroenterology; 1990 Aug; 37(4):432-5. PubMed ID: 2170259 [TBL] [Abstract][Full Text] [Related]